Agios Pharma (AGIO)
NASDAQ:AGIO
Holding AGIO?
Track your performance easily

Agios Pharma (AGIO) Financial Statements

570 Followers

Agios Pharma Financial Overview

Agios Pharma's market cap is currently ―. The company's EPS TTM is $-6.491; its P/E ratio is -7.02; Agios Pharma is scheduled to report earnings on October 31, 2024, and the estimated EPS forecast is $-1.71. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 8.62M$ 8.19M$ 7.10M$ 7.40M$ 6.71M
Gross Profit$ 7.12M$ 7.56M$ 6.52M$ 6.77M$ 5.60M
EBIT$ -96.12M$ -81.55M$ -106.28M$ -91.32M$ -83.81M
EBITDA$ -89.14M$ -79.92M$ -104.87M$ -85.92M$ -82.31M
Net Income Common Stockholders$ -96.12M$ -81.55M$ -95.94M$ -91.32M$ -83.81M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 569.89M$ 597.99M$ 776.93M$ 647.49M$ 702.57M
Total Assets$ 773.06M$ 849.71M$ 937.12M$ 1.01B$ 1.09B
Total Debt$ 64.62M$ 68.35M$ 72.00M$ 75.50M$ 78.95M
Net Debt$ -505.27M$ -529.64M$ -704.93M$ -571.99M$ -623.62M
Total Liabilities$ 112.55M$ 105.79M$ 126.10M$ 120.42M$ 120.92M
Stockholders Equity$ 660.51M$ 743.92M$ 811.02M$ 886.84M$ 964.24M
Cash Flow-
Free Cash Flow$ -72.75M$ -99.97M$ -72.72M$ -60.84M$ -66.75M
Operating Cash Flow$ -72.59M$ -99.87M$ -72.49M$ -61.64M$ -66.75M
Investing Cash Flow$ 37.24M$ 124.56M$ 95.51M$ 39.34M$ 47.13M
Financing Cash Flow$ 1.10M$ 5.86M$ 847.00K$ 1.88M$ 237.00K
Currency in USD

Agios Pharma Earnings and Revenue History

Agios Pharma Debt to Assets

Agios Pharma Cash Flow

Agios Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis